A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke

NCT06755944 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ENROLLING_BY_INVITATION

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke, Ischemic

Interventions

DRUG: XY03-EA

Sponsor

Shijiazhuang Yiling Pharmaceutical Co. Ltd